/PRNewswire/ Intrinsic Therapeutics, Inc., the developer of the Barricaid, an FDA approved medical device proven to significantly reduce reherniations and.
CIGNA Covers Barricaid – to Prevent Re-Herniation | Orthopedics This Week ryortho.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ryortho.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Intrinsic Therapeutics, Inc., a medical device company focused on preventing reherniation and reoperation following lumbar discectomy, today.
BioSenic appoints Lieven Huysse, MD, as Chief Medical Officer finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.